tradingkey.logo

Soleno Therapeutics Announces Preliminary Financial And Operational Results for Q2

ReutersJul 10, 2025 10:49 AM

- Soleno Therapeutics Inc SLNO.O:

  • SOLENO THERAPEUTICS ANNOUNCES PRELIMINARY FINANCIAL AND OPERATIONAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2025

  • SOLENO THERAPEUTICS: EXPECTS NET REVENUE FROM SALES OF VYKAT(TM) XR, FOR THREE MONTHS ENDED JUNE TO BE BETWEEN $31.0 MILLION - $33.0 MILLION

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI